MG
0
Active Trials
0
Total Trials
0
Organizations
0
Events
Madagascar
Medical Only (Private)
Reimbursed Care Access
Madagascar maintains a restrictive, prohibition-focused approach to classical psychedelics (psilocybin, MDMA, DMT, mescaline, 5‑MeO‑DMT, ibogaine and synthetic phenethylamines), which carry no authorised medical use outside regulated research. Ketamine is widely used and available as an anaesthetic in public and private hospitals; however, newer psychedelic-derived therapeutics such as esketamine (Spravato) do not appear to have a documented national registration or public reimbursement pathway in Madagascar.
No clinical trials found for this country yet.